The Sustainable Development Goals (SDGs) were adopted by all United Nations Member States in 2015, to advance development for people and the planet by 2030.
Our CEO, Michael Anderson, served as the UK Prime Minister’s Special Envoy for the UN Development Goals. He was intimately involved in the development of the SDGs and the targets associated with them.
I was personally privileged to help draft the SDG principle of ‘leave no one behind’. That spirit is central to every MedAccess investment. Improving access to medicines in underserved markets is an effective way to promote health and well-being for all through sustainable partnerships.
Our work is aligned with the SDG agenda, particularly through the realisation of the following goals.
Medical products can save and change lives. But only if they reach the people who need them, when they need them. Nearly two billion people are currently living without access to basic medicines.
Our innovative finance tools work specifically to accelerate access to modern and effective healthcare supplies for people in low- and middle-income countries.
Market failures lead to unequal healthcare provision within and among countries. High-income countries are typically able to provide access to newer products more quickly, while people in low- and middle-income countries often wait years – or even decades – for access to the same medicines, tests and treatments.
Our guarantees seek to ensure countries can introduce new healthcare products more quickly.
With donor budgets under renewed pressure, alternative funding methods and long-term cost savings are becoming increasingly important. Our guarantees catalyse partnerships between countries, procurers, manufacturers and distributors, by reducing risks and lowering prices.
Although we primarily contract with manufacturers, all our transactions are supported by strong partnerships that ensure products get from the factories to the people that need them.